The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Regulatory News (COA)

Share Price Information for Coats (COA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.90
Bid: 81.90
Ask: 82.30
Change: 1.40 (1.74%)
Spread: 0.40 (0.488%)
Open: 82.20
High: 82.50
Low: 80.50
Prev. Close: 80.50
COA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK pension scheme update

6 Dec 2022 07:00

RNS Number : 6730I
Coats Group PLC
06 December 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

6 December 2022

Coats Group plc

A major step forward with partial buy-in of UK defined benefit pension scheme

Coats Group plc ("Coats" or the "Group") is pleased to announce that the trustee of the Coats UK Pension Scheme ("the scheme") has purchased a c£350m bulk annuity policy from Aviva which insures benefits payable under the scheme in respect of c3,700 pensioner and dependant members. These members represent roughly 20% of the scheme's liabilities.

The purchase of this policy sees all the scheme's financial and demographic risks fully hedged for the covered liabilities. The scheme will receive a regular stream of income that matches the pension payments for the covered members, making it a precise liability hedging asset, thus further de-risking the scheme and reducing future balance sheet volatility. This builds on the significant positive steps to de-risk the scheme in recent years through which 90% of the scheme's inflation / interest rate exposure had previously been hedged.

The Aviva buy-in is consistent with Coats' aspiration of fully insuring the scheme and removing it from the Group balance sheet. Once the scheme is fully funded and cash contributions cease, the Group's free cash generation will improve significantly allowing increased investment in growth or the return of excess capital to shareholders.

When the Technical Provisions deficit for the scheme was last formally assessed at 31 March 2021, as part of the triennial valuation cycle, it showed a £193m deficit. Updates since then indicate that the deficit had fallen closer to £55m by mid-November 2022, with a further reduction to £25m-£30m expected following the buy-in.

The Group will provide a further update at its 2022 full year results presentation in March 2023.

 

Conference call

The Group will host a call at 8am today covering this statement. Join the call by dialling +44 (0) 333 300 9035. A short presentation is also available on our website.

 

Jackie Callaway, Chief Financial Officer, said:

"The purchase of this bulk annuity policy represents an important step in further de-risking our UK defined benefit pension scheme. It moves us closer to eliminating our Technical Provisions deficit and achieving our ultimate plan of fully insuring, in a cost effective manner, the scheme and moving it off our balance sheet. Once the scheme is fully funded and cash contributions cease this will lead to a significant improvement in the Group's free cash generation. The completion of the buy-in reflects the constructive and collaborative working relationship between the Group and the trustee and I would like to thank all involved for helping us get to this position, which will benefit all stakeholders."

 

 

Enquiry details

 

 

 

 

Investors

Chris Dyett

Coats Group plc

+44 (0)79 7497 4690

 

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

Notes

1. The Coats UK Pension Scheme is Coats Group plc's sole defined benefit pension scheme in the UK, having been formed from the merger of three legacy pension schemes in 2018.

2. The policy, commonly termed a pensioner "buy-in", is underwritten by Aviva Life and Pensions UK Limited, a leading UK life insurance business specialising in bulk annuity contracts.

3. Aviva was selected by the scheme trustee following a competitive selection process overseen by a joint working group established between Coats and the trustee.

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenues in 2021 were $1.8bn.

Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries.

With a proud heritage dating back more than 250 years and spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a workforce of over 17,000, serving its customers worldwide. 

Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are three dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to Science Based sustainability targets for 2030 and beyond, with a goal of achieving net-zero by 2050. Coats is also committed to achieving its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance.

To find out more about Coats visit www.coats.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEASEEKAFAA
Date   Source Headline
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement
11th Nov 202211:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.